Postdischarge Assessment After a Heart Failure Hospitalization
2010; Lippincott Williams & Wilkins; Volume: 122; Issue: 18 Linguagem: Inglês
10.1161/circulationaha.110.982207
ISSN1524-4539
AutoresMarco Metra, Mihai Gheorghiade, Robert O. Bonow, Livio Dei,
Tópico(s)Cardiovascular Function and Risk Factors
ResumoHomeCirculationVol. 122, No. 18Postdischarge Assessment After a Heart Failure Hospitalization Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBPostdischarge Assessment After a Heart Failure HospitalizationThe Next Step Forward Marco Metra, MD, Mihai Gheorghiade, MD, Robert O. Bonow, MD and Livio Dei Cas, MD Marco MetraMarco Metra From Cardiology, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy (M.M., L.D.C.), and Division of Cardiology and Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Ill (M.G., R.O.B.). , Mihai GheorghiadeMihai Gheorghiade From Cardiology, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy (M.M., L.D.C.), and Division of Cardiology and Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Ill (M.G., R.O.B.). , Robert O. BonowRobert O. Bonow From Cardiology, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy (M.M., L.D.C.), and Division of Cardiology and Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Ill (M.G., R.O.B.). and Livio Dei CasLivio Dei Cas From Cardiology, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy (M.M., L.D.C.), and Division of Cardiology and Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Ill (M.G., R.O.B.). Originally published18 Oct 2010https://doi.org/10.1161/CIRCULATIONAHA.110.982207Circulation. 2010;122:1782–1785Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: October 18, 2010: Previous Version 1 Heart failure (HF) is the most frequent cause of hospitalization for patients >65 years of age.1–5 More than 1 million patients are admitted to the hospital with HF each year in the United States, and this number is likely to increase because of aging of the general population, improved survival after acute cardiovascular conditions, and prevention of sudden cardiac death. Hospitalization for HF is one of the most powerful independent risk factors for death among patients with HF. Mortality during the initial hospitalization ranges from 6% to 7% in Europe to 3% to 4% in the United States, depending on the length of hospital stay.1,2 Poor outcomes have universally been shown after discharge, with 60- to 90-day mortality rates of 5% to 15% and hospital readmission rates of 30%.1,6,7 Depending on the duration of the first hospitalization and on the number of previous hospitalizations, the risk of dying after a hospitalization for HF is increased from 4-fold to 16-fold compared with before the hospitalization.8Article see p 1806Whereas the prognosis of patients with chronic HF has improved in recent years, there has been no change in the high risk of death or rehospitalization after an HF hospitalization.6,9–11 This has multiple causes. First, the hospitalization for HF may be the expression of end-stage HF. In these patients, all therapies have already been tried and have become ineffective or were not tolerated. There are no chances to improve their symptoms and prognosis except with the use of assist devices or heart transplantation. These patients, however, are only a small proportion, <5%, of all the patients hospitalized for HF. An improvement in outcomes is possible in the others.1,12 In addition to the lack of new therapies, incomplete relief from fluid overload, insufficient patient education, lack of implementation of evidence-based therapies, and poor postdischarge follow-up planning are among the main causes of their poor outcomes.2–4The transition from the in-hospital to the outpatient setting involves not only changes in the physician(s) providing care but also modifications in diet, self-dependence in the administration of new and complex drug therapies, demands for more physical activity, and confrontation with familial and social stresses. All of these factors make the early postdischarge period a vulnerable phase. Changes in fluid status and/or renal function frequently occur, and outcomes may be deeply affected.5,13 In addition, uptitration of lifesaving therapies such as neurohormonal antagonists may require many weeks, and thus only an early postdischarge follow-up may allow its completion. Postdischarge assessment is now deemed an essential component of the treatment of the patients hospitalized for HF.2–4 It directly follows the 3 earlier phases of evaluation and management of the patients with acute HF, summarized as the early or emergency department (ED) phase, the in-hospital phase, and the predischarge phase.2,7,13 However, it remains to be established who should perform the postdischarge assessment, in which patients and when it should take place, and what should be its components.2–4In this issue of Circulation, Lee et al14 relate the type of transition care with the outcomes of 10 599 patients with HF evaluated at EDs in Ontario, Canada, between April 1, 2004, and March 31, 2007. Data obtained with the National Ambulatory Care Reporting System clearly demonstrate the benefits of a postdischarge assessment performed by both the primary care (PC) physician and the cardiologist compared with the lack of any physician assessment but also with PC-only practice.Who Should Perform Postdischarge Assessment?The study by Lee et al provides answers to this question. Lee et al subdivided patients into 4 groups according to their postdischarge care: no physician visit (n=1990), PC only (n=6596), cardiologist only (n=535), and collaborative care including a PC physician and a cardiologist (n=1478). Internal medicine specialists who provided cardiology care were considered cardiac specialists. Compared with PC, collaborative care patients were more likely to undergo an assessment of left ventricular function (57.4% versus 28.7%), noninvasive stress testing (20.1% versus 7.8%), and cardiac catheterization (11.6% versus 2.7%). They were also more likely to be treated with angiotensin-converting enzyme inhibitors (58.8% versus 54.6%), angiotensin receptor blockers (22.7% versus 18.1%), β-blockers (63.4% versus 48.0%), spironolactone (19.8% versus 12.7%), and loop diuretics. In a propensity-matched model, PC was associated with significantly lower mortality compared with no physician evaluation (P<0.001), thus showing the benefits of postdischarge follow-up. Collaborative care further reduced mortality compared with PC (P<0.001). Similar results were found for the composite end points of death, ED visits, and HF rehospitalization (the Figure), as well as for all-cause ED visits, rehospitalizations, and deaths.14Download figureDownload PowerPointFigure. Mortality rates (left) and rates of deaths, ED visits, and hospitalizations for HF (right) in the patients with different postdischarge follow-up. Collaborative care indicates care by both a PC physician and a cardiologist. *P=0.004; **P 30% of patients who underwent ED evaluation for HF were discharged without hospital admission in a similar cohort of patients.16 The present study may lack data regarding clinical characteristics, comorbidities, and in-hospital course of the patients, so meaningful variables may not have been included in the propensity analysis. These limitations are acknowledged by the authors and are expected in studies based on the examination of large registries.Despite its rationale, postdischarge assessment has been examined only recently.5,7 Hernandez et al17 have recently assessed the relationship between early physician follow-up and 30-day outcomes among 30 136 Medicare beneficiaries hospitalized for HF. Consistent with the study of Lee et al, discharge from hospitals in which a greater proportion of patients received early follow-up evaluation was independently associated with lower rates of all-cause readmissions, although mortality was not affected.17When Should the Postdischarge Assessment Be Performed?As outlined above, the vulnerable phase occurs just after discharge from hospital. The incidence of death or rehospitalizations sharply increases early after discharge and gradually decreases thereafter, following an almost exponential pattern.8,18 This suggests that an early assessment, ie, 1 to 2 weeks after discharge, should yield the greatest benefit.Which Patients?The number of patients hospitalized for HF is so large that a postdischarge assessment strategy cannot be proposed for all. Ideally, postdischarge assessment should include only the patients who, in the predischarge phase, are found to be at high risk of cardiac events. Simple but powerful predictors of postdischarge events include blood pressure, QRS duration, renal dysfunction, serum levels of sodium, natriuretic peptides and troponin, and other comorbidities.1,5,19 The hospital length of stay and the number of previous rehospitalizations are also major prognostic variables.8,9,18What Should the Postdischarge Assessment Accomplish?The postdischarge evaluation provides the opportunity to reassess fluid status, to provide additional patient education, to review medications and adjust their doses, and to plan for additional diagnostic and interventional procedures. Goals may target multiple mechanisms of HF, ranging from the prevention and treatment of congestion, and hence rehospitalization, to the improvement in symptoms and skeletal muscle function to beneficial cardiac remodeling, improvement in cardiac function, and enhanced prognosis.7The study by Lee et al14 suggests that the implementation of diagnostic examinations and evidence-based therapies by the PC physician and the cardiologist may favorably affect outcomes.1,5,7,18 The importance of the components of the post-discharge assessment, suggested in the Table, will have to be examined by future studies, since they have not been tested in the post-discharge phase. Their application in clinical practice may successfully turn the hospitalization for HF from an ominous event heralding a poor prognosis to an opportunity to improve patient outcomes through education, correction of pathogenetic mechanisms and implementation of evidence based therapies.Table. Components of Early Postdischarge Follow-UpActionExpected OutcomesPrevention of Fluid OverloadImprovement in SymptomsImprovement in PrognosisEducation Diet+++++ Exercise+++ Medications (benefits, side effects)+++++ Weight monitoring++++ Detection and treatment of worsening symptoms++++Assessment of compliance Medical therapy+++++ Nonpharmacological prescriptions (diet, exercise, weight monitoring)+++++Assessment of prognostic variables Clinical Signs of congestion: pulmonary rales, jugular venous congestion, hepatomegaly, peripheral edema++++++ Blood pressure+?+ Heart rate?+ (?)+ Orthostatic test+?? Valsalva maneuver+?? ECG QRS duration, indication to CRT++++++ Atrial fibrillation, tachyarrhythmias+ (?)+++ Laboratory examinations Myocardial viability*++++ (?) Natriuretic peptides++++ Renal function and electrolytes++/0+/++ (?) Anemia and/or iron deficiency?++? Devices for fluid status monitoring+++++ (++?)Optimization of medical treatment Changes in diuretic doses according to fluid status+++++ (?) Initiation or uptitration of evidence-based therapies (renin-angiotensin-aldosterone antagonists, β-blockers, digoxin)+++++ CRT when indicated++++++ ICD when indicated00+++ Coronary revascularization when indicated+++ (?) Other surgical procedures (eg, mitral valve surgery)++?CRT indicates cardiac resynchronization therapy; ICD, implantable cardioverter defibrillator.*Viable but dysfunctional and potentially salvageable myocardium.DisclosuresDr Metra has received honoraria for participating in steering committees and advisory boards and giving speeches from Cardiokine, Corthera, Merck, and Servier. Dr Gheorghiade has served as a consultant for Abbott Laboratories, Astellas, AstraZeneca, Bayer Schering Pharma AG, CorThera, Cytokinetics, DebioPharm S.A., Errekappa Terapeutici, GlaxoSmithKline, Ikaria, Johnson & Johnson, Medtronic, Merck, Novartis Pharma AG, Otsuka Pharmaceuticals, Palatin Technologies, Pericor Therapeutics, Protein Design Laboratories, Sanofi-Aventis, Sigma Tau, Solvay Pharmaceuticals, and Trevena Therapeutics; and has received significant (>$10 000) support from Bayer Schering Pharma AG, DebioPharm S.A., Medtronic, Novartis Pharma AG, Otsuka Pharmaceuticals, Sigma Tau, Solvay Pharmaceuticals, and Pericor Therapeutics. The other authors report no conflicts.FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to Professor Marco Metra, Cardiologia c/o Spedali Civili, P.zza Spedali Civili, 25100 Brescia, Italy. E-mail [email protected]itReferences1. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009; 53:557–573.CrossrefMedlineGoogle Scholar2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Tendera M, Auricchio A, Bax J, Böhm M, Corrà U, della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zamorano JL, Zannad F. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008; 10:933–989.CrossrefMedlineGoogle Scholar3. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119:1977–2016.LinkGoogle Scholar4. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010; 16:475–539.CrossrefGoogle Scholar5. Gheorghiade M, Bonow RO. Heart failure: early follow-up after hospitalization for heart failure. Nat Rev Cardiol. 2010; 7:422–424.CrossrefMedlineGoogle Scholar6. Ross JS, Chen J, Lin Z, Bueno H, Curtis JP, Keenan PS, Normand SL, Schreiner G, Spertus JA, Vidán MT, Wang Y, Wang Y, Krumholz HM. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2010; 3:97–103.LinkGoogle Scholar7. Pang PS, Komajda M, Gheorghiade M. The current and future management of acute heart failure syndromes. Eur Heart J. 2010; 31:784–793.CrossrefMedlineGoogle Scholar8. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MACandesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007; 116:1482–1487.LinkGoogle Scholar9. Curtis LH, Greiner MA, Hammill BG, Kramer JM, Whellan DJ, Schulman KA, Hernandez AF. Early and long-term outcomes of heart failure in elderly persons, 2001–2005. Arch Intern Med. 2008; 168:2481–2488.CrossrefMedlineGoogle Scholar10. Bernheim SM, Grady JN, Lin Z, Wang Y, Wang Y, Savage SV, Bhat KR, Ross JS, Desai MM, Merrill AR, Han LF, Rapp MT, Drye EE, Normand SL, Krumholz HM. National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure: update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes. 2010; 3:459–467.LinkGoogle Scholar11. Heidenreich PA, Sahay A, Kapoor JR, Pham MX, Massie B. Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006. J Am Coll Cardiol. 2010; 56:362–368.CrossrefMedlineGoogle Scholar12. Metra M, Ponikowski P, Dickstein K, McMurray JJ, Gavazzi A, Bergh CH, Fraser AG, Jaarsma T, Pitsis A, Mohacsi P, Bohm M, Anker S, Dargie H, Brutsaert D, Komajda MHeart Failure Association of the European Society of Cardiology. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2007; 9:684–694.CrossrefMedlineGoogle Scholar13. Blair JE, Khan S, Konstam MA, Swedberg K, Zannad F, Burnett JC, Grinfeld L, Maggioni AP, Udelson JE, Zimmer CA, Ouyang J, Chen CF, Gheorghiade MEVEREST Investigators. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009; 30:1666–1673.CrossrefMedlineGoogle Scholar14. Lee DS, Stukel TA, Austin PC, Alter DA, Schull MJ, You JJ, Chong A, Henry D, Tu JV. Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department. Circulation. 2010; 122:1806–1814.LinkGoogle Scholar15. Jong P, Gong Y, Liu PP, Austin PC, Lee DS, Tu JV. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation. 2003; 108:184–191.LinkGoogle Scholar16. Lee DS, Schull MJ, Alter DA, Austin PC, Laupacis A, Chong A, Tu JV, Stukel TA. Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail. 2010; 3:228–235.LinkGoogle Scholar17. Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010; 303:1716–1722.CrossrefMedlineGoogle Scholar18. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007; 154:260–266.CrossrefMedlineGoogle Scholar19. Metra M, Felker GM, Zacà V, Bugatti S, Lombardi C, Bettari L, Voors AA, Gheorghiade M, Dei Cas L. Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy [published online ahead of print May 25, 2010]. Int J Cardiol.doi: 10.1016/j.ijcard.2010.04.003.Google Scholar20. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the heart Failure Association of the European SOCIETY of cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010; 12:423–433.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Canepa M, Leporatti L, Persico L, Ameri P, Porto I, Ansaldi F and Montefiori M (2022) Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy, International Journal of Cardiology, 10.1016/j.ijcard.2022.06.052, Online publication date: 1-Jun-2022. McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland J, Coats A, Crespo-Leiro M, Farmakis D, Gilard M, Heyman S, Hoes A, Jaarsma T, Jankowska E, Lainscak M, Lam C, Lyon A, McMurray J, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano G, Ruschitzka F and Skibelund A (2022) Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica, Revista Española de Cardiología, 10.1016/j.recesp.2021.11.027, 75:6, (523.e1-523.e114), Online publication date: 1-Jun-2022. McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland J, Coats A, Crespo‐Leiro M, Farmakis D, Gilard M, Heymans S, Hoes A, Jaarsma T, Jankowska E, Lainscak M, Lam C, Lyon A, McMurray J, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano G, Ruschitzka F, Kathrine Skibelund A, de Boer R, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker S, Arbelo E, Asteggiano R, Bauersachs J, Bayes‐Genis A, Borger M, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale C, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis B, Leyva F, Linhart A, Løchen M, Lund L, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen S, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter D, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa‐Uva M, Tocchetti C, Touyz R, Tschoepe C and Waltenberger J (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, European Journal of Heart Failure, 10.1002/ejhf.2333, 24:1, (4-131), Online publication date: 1-Jan-2022. McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland J, Coats A, Crespo-Leiro M, Farmakis D, Gilard M, Heymans S, Hoes A, Jaarsma T, Jankowska E, Lainscak M, Lam C, Lyon A, McMurray J, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano G, Ruschitzka F, Kathrine Skibelund A, de Boer R, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker S, Arbelo E, Asteggiano R, Bauersachs J, Bayes-Genis A, Borger M, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale C, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis B, Leyva F, Linhart A, Løchen M, Lund L, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J, Neubeck L, Noutsias M, Petersen S, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter D, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-Uva M, Tocchetti C, Touyz R, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland J, Coats A, Crespo-Leiro M, Farmakis D, Gardner R, Gilard M, Heymans S, Hoes A, Jaarsma T, Jankowska E, Lainscak M, Lam C, Lyon A, McMurray J, Mebazaa A, Mindham R, Muneretto C, Piepoli M, Price S, Rosano G, Ruschitzka F and Skibelund A (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, European Heart Journal, 10.1093/eurheartj/ehab368, 42:36, (3599-3726), Online publication date: 21-Sep-2021. Löfman I, Szummer K, Evans M, Carrero J, Lund L and Jernberg T (2019) Incidence of, Associations With and Prognostic Impact of Worsening Renal Function in Heart Failure With Different Ejection Fraction Categories, The American Journal of Cardiology, 10.1016/j.amjcard.2019.07.065, 124:10, (1575-1583), Online publication date: 1-Nov-2019. Waters S and Giblin E (2019) Acute Heart Failure: Pearls for the First Posthospitalization Clinic Visit, The Journal for Nurse Practitioners, 10.1016/j.nurpra.2018.08.031, 15:1, (80-86), Online publication date: 1-Jan-2019. Bilchick K, Moss T, Welch T, Levy W, Stukenborg G, Lawlor B, Reigle J, Thomas S, Brady C, Bergin J, Kennedy J, Abuannadi M, Scully K and Mazimba S (2018) Improving Heart Failure Readmission Costs and Outcomes With a Hospital-to-Home Readmission Intervention Program, American Journal of Medical Quality, 10.1177/1062860618788436, 34:2, (127-135), Online publication date: 1-Mar-2019. Ponikowski P, Spoletini I, Coats A, Piepoli M and Rosano G (2019) Heart rate and blood pressure monitoring in heart failure, European Heart Journal Supplements, 10.1093/eurheartj/suz217, 21:Supplement_M, (M13-M16), Online publication date: 1-Dec-2019. Chioncel O, Collins S, Ambrosy A, Pang P, Antohi E, Iliescu V, Maggioni A, Butler J and Mebazaa A (2018) Improving Postdischarge Outcomes in Acute Heart Failure, American Journal of Therapeutics, 10.1097/MJT.0000000000000791, 25:4, (e475-e486), Online publication date: 1-Jul-2018. Pang P, Collins S, Butler J and Chioncel O (2018) Mihai Gheorghiade, MD—Life and Concepts, American Journal of Therapeutics, 10.1097/MJT.0000000000000797, 25:4, (e453-e455), Online publication date: 1-Jul-2018. Purba D and Hasan R (2018) PREDICE score as a predictor of 90 days mortality in patients with heart failure, IOP Conference Series: Earth and Environmental Science, 10.1088/1755-1315/125/1/012123, 125, (012123), Online publication date: 1-Mar-2018. Njoroge J, Cheema B, Ambrosy A, Greene S, Collins S, Vaduganathan M, Mebazaa A, Chioncel O, Butler J and Gheorghiade M (2018) Expanded algorithm for managing patients with acute decompensated heart failure, Heart Failure Reviews, 10.1007/s10741-018-9697-9, 23:4, (597-607), Online publication date: 1-Jul-2018. Cheema B, Ambrosy A, Kaplan R, Senni M, Fonarow G, Chioncel O, Butler J and Gheorghiade M (2017) Lessons learned in acute heart failure, European Journal of Heart Failure, 10.1002/ejhf.1042, 20:4, (630-641), Online publication date: 1-Apr-2018. Zahid I, Baig M, Ahmed Gilani J, Waseem N, Ather S, Farooq A, Ghouri A, Siddiqui S, Kumar R, Sahil , Suman , Kumar R, kumar R, Mulla A, Siddiqi R and Fatima K (2018) Frequency and predictors of depression in congestive heart failure, Indian Heart Journal, 10.1016/j.ihj.2018.10.410, 70, (S199-S203), Online publication date: 1-Dec-2018. Moayedi Y, Schofield T, Etchells E, Silver S, Kobulnik J, McQuillan R, Bell C, Linghorne M and Ross H (2017) Closing the Care Gap, Circulation: Heart Failure, 10:5, Online publication date: 1-May-2017. Vaduganathan M, Patel R, Butler J and Metra M (2017) Integrating electronic health records into the study of heart failure: promises and pitfalls, European Journal of Heart Failure, 10.1002/ejhf.878, 19:9, (1128-1130), Online publication date: 1-Sep-2017. Maru S, Byrnes J, Carrington M, Stewart S and Scuffham P (2016) Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study, Journal of Medical Economics, 10.1080/13696998.2016.1261031, 20:4, (318-327), Online publication date: 3-Apr-2017. Moayedi Y and Ross H (2017) Advances in heart failure: a review of biomarkers, emerging pharmacological therapies, durable mechanical support and telemonitoring, Clinical Science, 10.1042/CS20160196, 131:7, (553-566), Online publication date: 1-Apr-2017. Andreu-Cayuelas J, Pastor-Pérez F, Puche C, Mateo-Martínez A, García-Alberola A, Flores-Blanco P, Valdés M, Lip G, Roldán V and Manzano-Fernández S (2016) Repercusiones en la posología de los anticoagulantes orales no antagonistas de la vitamina K por las variaciones de la función renal de los pacientes con fibrilación auricular e insuficiencia cardiaca aguda reciente, Revista Española de Cardiología, 10.1016/j.recesp.2015.06.022, 69:2, (134-140), Online publication date: 1-Feb-2016. Andreu-Cayuelas J, Pastor-Pérez F, Puche C, Mateo-Martínez A, García-Alberola A, Flores-Blanco P, Valdés M, Lip G, Roldán V and Manzano-Fernández S (2016) Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure, Revista Española de Cardiología (English Edition), 10.1016/j.rec.2015.06.021, 69:2, (134-140), Online publication date: 1-Feb-2016. Saldarriaga C, Garcés J, Agudelo A, Guarín L and Mejía J (2016) Impacto clínico de un programa de falla cardiaca, Revista Colombiana de Cardiología, 10.1016/j.rccar.2015.06.012, 23:4, (260-264), Online publication date: 1-Jul-2016. Greene S, Fonarow G, Vaduganathan M, Khan S, Butler J and Gheorghiade M (2015) The vulnerable phase after hospitalization for heart failure, Nature Reviews Cardiology, 10.1038/nrcardio.2015.14, 12:4, (220-229), Online publication date: 1-Apr-2015. Messina G, Forni S, Collini F, Galdo A, Di Fabrizio V and Nante N (2018) Short-Term Adjusted Outcomes for Heart Failure, Heart International, 10.5301/heartint.5000220, 10:1, (heartint.500022), Online publication date: 1-Jan-2015. Parrinello G, Greene S, Torres D, Alderman M, Bonventre J, Di Pasquale P, Gargani L, Nohria A, Fonarow G, Vaduganathan M, Butler J, Paterna S, Stevenson L and Gheorghiade M (2014) Water and Sodium in Heart Failure: A Spotlight on Congestion, Heart Failure Reviews, 10.1007/s10741-014-9438-7, 20:1, (13-24), Online publication date: 1-Jan-2015. Kinugasa Y, Kato M, Sugihara S, Yanagihara K, Yamada K, Hirai M and Yamamoto K (2014) Multidisciplinary intensive education in the hospital improves outcomes for hospitalized heart failure patients in a Japanese rural setting, BMC Health Services Research, 10.1186/1472-6963-14-351, 14:1, Online publication date: 1-Dec-2014. Shimizu Y, Suzuki M, Okumura H and Yamada S (2014) Risk factors for onset of depression after heart failure hospitalization, Journal of Cardiology, 10.1016/j.jjcc.2013.11.003, 64:1, (37-42), Online publication date: 1-Jul-2014. Ambrosy A, Fonarow G, Butler J, Chioncel O, Greene S, Vaduganathan M, Nodari S, Lam C, Sato N, Shah A and Gheorghiade M (2014) The Global Health and Economic Burden of Hospitalizations for Heart Failure, Journal of the American College of Cardiology, 10.1016/j.jacc.2013.11.053, 63:12, (1123-1133), Online publication date: 1-Apr-2014. Collins S, Pang P, Fonarow G, Yancy C, Bonow R and Gheorghiade M (2013) Is Hospital Admission for Heart Failure Really Necessary?, Journal of the American College of Cardiology, 10.1016/j.jacc.2012.08.1022, 61:2, (121-126), Online publication date: 1-Jan-2013. Metra M (2013) Tachycardia After a Heart Failure Hospitalization, JACC: Heart Failure, 10.1016/j.jchf.2013.10.003, 1:6, (497-499), Online publication date: 1-Dec-2013. Gheorghiade M, Vaduganathan M, Fonarow G and Bonow R (2013) Rehospitalization for Heart Failure, Journal of the American College of Cardiology, 10.1016/j.jacc.2012.09.038, 61:4, (391-403), Online publication date: 1-Jan-2013. Gheorghiade M and Nodari S (2013) Hospitalizations for Heart Failure, Heart Failure Clinics, 10.1016/j.hfc.2013.05.003, 9:3, (xi-xii), Online publication date: 1-Jul-2013. Parrinello G, Torres D, Paterna S, Di Pasquale P, Trapanese C, Cardillo M, Bellanca M, Fasullo S and Licata G (2011) Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure, Internal and Emergency Medicine, 10.1007/s11739-011-0602-y, 8:3, (221-228), Online publication date: 1-Apr-2013. Gheorghiade M, Vaduganathan M, Ambrosy A, Böhm M, Campia U, Cleland J, Fedele F, Fonarow G, Maggioni A, Mebazaa A, Mehra M, Metra M, Nodari S, Pang P, Ponikowski P, Sabbah H, Komajda M and Butler J (2012) Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure, Heart Failure Reviews, 10.1007/s10741-012-9315-1, 18:2, (107-122), Online publication date: 1-Mar-2013. Vaduganathan M, Greene S, Ambrosy A, Gheorghiade M and Butler J (2013) The disconnect between phase II and phase III trials of drugs for heart failure, Nature Reviews Cardiology, 10.1038/nrcardio.2012.181, 10:2, (85-97), Online publication date: 1-Feb-2013. Ambrosy A, Vaduganathan M, Huffman M, Khan S, Kwasny M, Fought A, Maggioni A, Swedberg K, Konstam M, Zannad F and Gheorghiade M (2014) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial, European Journal of Heart Failure, 10.1093/eurjhf/hfs007, 14:3, (302-311), Online publication date: 1-Mar-2012. Gheorghiade M, Pang P, Ambrosy A, Lan G, Schmidt P, Filippatos G, Konstam M, Swedberg K, Cook T, Traver B, Maggioni A, Burnett J, Grinfeld L, Udelson J and Zannad F (2011) A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial, Heart Failure Reviews, 10.1007/s10741-011-9280-0, 17:3, (485-509), Online publication date: 1-May-2012. Gheorghiade M, Albaghdadi M, Zannad F, Fonarow G, Böhm M, Gimpelewicz C, Botha J, Moores S, Lewis E, Rattunde H and Maggioni A (2014) Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT), European Journal of Heart Failure, 10.1093/eurjhf/hfq209, 13:1, (100-106), Online publication date: 1-Jan-2011. Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A, Wegscheider K, Treszl A, Meinertz T, Oeff M, Ravens U, Breithardt G and Steinbeck G (2017) Impact of the type of centre on management of AF patients: Surprising evidence for differences in antithrombotic therapy decisions, Thrombosis and Haemostasis, 10.1160/TH11-02-0070, 105:06, (1010-1023), . Blair J, Pang P, Schrier R, Metra M, Traver B, Cook T, Campia U, Ambrosy A, Burnett J, Grinfeld L, Maggioni A, Swedberg K, Udelson J, Zannad F, Konstam M and Gheorghiade M (2011) Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial, European Heart Journal, 10.1093/eurheartj/ehr238, 32:20, (2563-2572), Online publication date: 2-Oct-2011. Watson A, O'Rourke J, Jethwani K, Cami A, Stern T, Kvedar J, Chueh H and Zai A (2011) Linking Electronic Health Record-Extracted Psychosocial Data in Real-Time to Risk of Readmission for Heart Failure, Psychosomatics, 10.1016/j.psym.2011.02.007, 52:4, (319-327), Online publication date: 1-Jul-2011. Padhukasahasram B, Reddy C, Li Y, Lanfear D and Passino C (2015) Joint Impact of Clinical and Behavioral Variables on the Risk of Unplanned Readmission and Death after a Heart Failure Hospitalization, PLOS ONE, 10.1371/journal.pone.0129553, 10:6, (e0129553) Seto E, Ross H, Tibbles A, Wong S, Ware P, Etchells E, Kobulnik J, Chibber T and Poon S (2020) A Mobile Phone–Based Telemonitoring Program for Heart Failure Patients After an Incidence of Acute Decompensation (Medly-AID): Protocol for a Randomized Controlled Trial, JMIR Research Protocols, 10.2196/15753, 9:1, (e15753) Johnson A, Routh S, Taylor C, Leopold M, Beatty K, McNamara D and Davis E (2022) Developing and Implementing an mHealth Heart Failure Self-care Program to Reduce Readmissions: Randomized Controlled Trial, JMIR Cardio, 10.2196/33286, 6:1, (e33286) November 2, 2010Vol 122, Issue 18 Advertisement Article InformationMetrics © 2010 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.110.982207PMID: 20956215 Originally publishedOctober 18, 2010 Keywordshospitalizationfollow-up studiesheart failureprognosisemergency departmentEditorialsPDF download Advertisement SubjectsCongenital Heart DiseaseHeart Failure
Referência(s)